Mayombian ethnic, vegetables low intake, insulin treatment, diabetic nephropathy and severe diabetic retinopathy are determinants of blindness in diabetic Africans
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [31]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM:To determine the frequency and causes of blindness in diabetic Africans.METHODS:The study was a cross-sectional survey carried out among known black diabetics consecutively admitted at the Teaching Hospital, University of Kinshasa, between 2005 and 2007. Examination methods included interviewer-administered structured questionnaire, eye examinations (visual acuity, tonometry, funduscopy), and fasting plasma glycaemia test.RESULTS:Of the 227 patients examined, 15.9% had blindness. Univariate analyses showed significant association between female, severity of diabetic retinopathy, Mayombian ethnic group, use of insulin treatment, low intake of vegetables, diabetic nephropathy, open angle glaucoma and blindness in all diabetics. After logistic regression, only diabetic nephropathy, use of insulin treatment, macular oedema, Mayombian ethnic group and vegetables low intake were the independent risk factors of blindness in all diabetics. However, after logistic regression in the sub-group with diabetic retinopathy, only open angle glaucoma and proliferative diabetic retinopathy were the independent determinants of blindness.CONCLUSION:The majority of the causes of blindness in these diabetic Africans are avoidable. It is recommended that appropriate diabetes care, nutrition education, periodic eye examination and laser photocoagulation facilities should be provided for treating diabetics in sub-Saharan Africa.

    Reference
    1 International Diabetes Federation. IDF DIABETES ATLAS Fifth edition, 2011. www.idf.org/diabetesatlas
    2 Evans J. Causes of blindness and partial sight in England and Wales 1990-1991. London:HMSO, 1995
    3 Kumar N, Goyder E, McKibbin M. The incidence of visual impairment due to diabetic retinopathy in Leeds. Eye (Lond) 2006;20(4):455-459
    4 Khanderkar R, Mohammed AJ. Visual disabilities among diabetics in Oman. Saudi Med J 2005;26(5):836-841
    5 Mvitu M, Kimenyembo W, Kaimbo wa Kaimbo D, Driven W, Muls E. Frequency of visual impairment and blindness in Congolese people with diabetes. Diabetic Medicine 2006, 23 (Suppl.4) (Posters), 608-753
    6 Nwosu SN. Low vision in Nigerians with diabetes mellitus. Doc Ophthalmol 2000;101(1):51-57
    7 Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F, Beya C. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovasc Prev Rehabil 2008;15(5):503-508
    8 International Diabetes Federation. Diabetes Atlas, 2nd ed, Brussels, IDF, 2003
    9 Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F, Beya C. Enquête sur les facteurs de risque des maladies non transmissibles à Kinshasa. Capitale de RD Congo. Selon l’approche QTEPS de l’OMS.Ministère de la Santé Publique. RD Congo. 2007
    10 Longo-Mbenza B, Kadima-Tshimanga B, Buassa-bu-Tsumbu B, M’Buyamba K Jr. Diets rich in vegetables and physical activity are associated with a decreased risk of pregnancy induced hypertension among rural women from Kimpese, DR Congo. Niger J Med 2008;17(1):45-49
    11 Grading diabetic retinopathy from stereoscopic colour fundus photographs:an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment of Diabetic Retinopathy Study Research Group. Ophtalmology 1991;98(5 Suppl):786-806
    12 Willinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110(9):1675-82
    13 Gross LJL, de Azevedo MJ, Silveiro SP, Canani LH, CaramonI ML, Zelmanovic T. Diabetic nephropathy:diagnosis, prevention and treatment. Diabetes care 2005;28(1):164-176
    14 Dandona L, Dandona R. Revision of visual impairment definitions in the International Statistical Classification of Diseases. BMC Med 2006;4:7
    15 Schemann JF, Inocencio F, de Lourdes Monteiro M, Andrade J, Auzemery A, Guelfi Y. Blindness and low vision in Cape Verde Islands:results of a national eye survey. Ophthalmic Epidemiol 2006;13(4):219-226
    16 Longo-Mbenza B, Nkondi Mbadi A Nsungu J, Mbungu Fuele S. Higher pulse pressure, systolic arterial hypertension, duration of diabetes and family history of diabetes in Central Africans. Int J Diabetes & Metabolism 2008;16:17-23
    17 Al-Till MI, Al-bdour MD, Ajlouni KM. Prevalence of blindness and visual impairment among Jordanian diabetics. Eur J Ophthalmol 2005; 15(1):62-68
    18 Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy and cardiovascular disease in NIDDM. Diabetes care 1996;19(11):1243-1248
    19 Roy MS, Skurnick J. Six-year incidence of visual loss in African Americans with type 1 diabetes mellitus:the New Jersey 725. Arch Ophthalmol 2007;125(8):1061-1067
    20 Overview of 6 years’ therapy of typeⅡ diabetes:a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995;44(11):1249-1258
    21 Kollarits CR, Kiess RD, Das A, Hall AM, Jordan EL Jr, Donovan JE. Diabetic retinopathy and insulin therapy in a rural diabetic population. Am J Ophthalmol 1984;97(6):709-714
    22 Tron’ko MD, Khalanhot MD, Kravchenko VI, Kul’chyns’ka IaB, Hur’ianov VH, Okhrimenko NV, Neshcheret AP. Gender-related risk of non-fatal stroke, myocardial infarction and blindness in the type 2 diabetic patients depend on the type of treatment. Lik Sprava 2006;(1-2):23-27
    23 The Diabetic Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-986
    24 Rowe S, MacLean CH, Sheckelle PG. Preventing visual loss from chronic eye disease in primary care:scientific review. JAMA 2004;291(12):1487-1495
    25 Javitt JC, McBean AM, Nicholson GA, Babish JD, Warren JL, Krakauer H. Undertreatment of glaucoma among black Americans. N Engl J Med 1991;325(20):1418-1422
    26 Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss:AREDS report No.8 Arch Ophthalmol 2001;119(10):1417-1436
    27 Klein R, Klein BE, Moss SE, Davis MD, Demets DL. The Wisconsin epidemiologic study of diabetic retinopathyⅡ. Prevalence and risk of diabetic retinopathy when age at diagnosis less than thirty years. Arch Ophtalmol 1984;102(4):520-526
    28 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association:clinical practice recommendations 2002. Diabetes care 2002;25Suppl 1:S1-147
    29 Klein R, Klein BE, Neider MW, Hubbard LD, Meuer SM, Brothers RJ et al. Diabetic retinopathy as detected using ophthalmoscopy, an non-mydriatic camera and a standard fundus camera. Ophthalmol 1985;92:485-491
    30 Moss SE, Klein R, Kessler SD, Richie KA. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 1985;92(4):62-67
    31 Fong DS, Gottieb J, Ferris FL 3rd, Klein R. Understanding the value of diabetic retinopathy screening. Arch Ophthalmol 2001;119(5):758-760
    Cited by
Get Citation

Mvitu Muaka Moise, Longo-Mbenza Benjamin, Cibanda Yokobo Enoch,/et al.Mayombian ethnic, vegetables low intake, insulin treatment, diabetic nephropathy and severe diabetic retinopathy are determinants of blindness in diabetic Africans. Int J Ophthalmol, 2013,6(5):727-732

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:August 20,2012
  • Revised:August 08,2013
  • Adopted:August 08,2013
  • Online: May 18,2013